Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BETAPAR

MEPREDNISONE

Standard Dose
4MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BETAPAR is listed in Drugs@FDA under application 016053 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MEPREDNISONE Form and strength TABLET;ORAL - 4MG Sponsor SCHERING Submission history Latest submission status date: 1980-10-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETAPAR is listed in Drugs@FDA under application 016053 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MEPREDNISONE Form and strength TABLET;ORAL - 4MG Sponsor SCHERING Submission history Latest submission status date: 1980-10-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.